九安医疗：10月24日召开董事会会议

Group 1 - The core point of the article is that Jiuan Medical (SZ 002432) held its 28th meeting of the sixth board of directors on October 24, 2025, to discuss investment proposals with professional investment institutions [1] - For the first half of 2025, Jiuan Medical's revenue composition was as follows: medical devices accounted for 87.74%, internet medical products and services accounted for 6.57%, retail business accounted for 5.03%, and other industries accounted for 0.66% [1] - As of the time of reporting, Jiuan Medical's market capitalization was 18.7 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas licenses worth 80 billion USD this year, highlighting the hot secondary market in biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]